Blood test might predict how well a depressed patient responds to antidepressants

Loyola University Medical Center researchers are reporting what could become the first reliable method to predict whether an antidepressant will work on a depressed patient.

The method would involve a blood test for a protein called (VEGF). A Loyola study found that among who had higher than normal blood levels of VEGF, more than 85 percent experienced partial or complete relief from depression after taking escitalopram (brand name Lexapro). By comparison, fewer than 10 percent of depressed patients who had low levels of VEGF responded to the drug.

"This would be the first time we would have a predictor for how well a patient would respond to an antidepressant," said Angelos Halaris, MD, PhD, first author of the study. Halaris presented results during the 2011 annual meeting of the Society of Biological Psychiatry and the 4th Annual Illinois Brain, Behavior and Immunity Meeting.

About 60 percent of depressed patients do not respond fully to the first prescribed medication. Consequently, doctors often must prescribe a different medication again and again before finding one that works. "It would greatly benefit our patients if we could predict ahead of time whether a given medication would be effective for a certain patient," Halaris said.

The Loyola study involved 35 patients who took escitalopram for . Escitalopram belongs to a class of antidepressants called (SSRIs). Other common SSRIs are Prozac®, Paxil® and Zoloft®.

Scientists aren't certain why SSRIs work in some patients but not in others. One possible mechanism is that SSRIs help restore a chemical balance in the brain. Some scientists recently have proposed a second possible mechanism, called neurogenesis -- SSRIs help to regenerate brain cells in specific parts of the brain that have atrophied in depressed patients.

The Loyola study supports the neurogenesis theory. It appears that escitalopram, the SSRI used in the Loyola study, jump-starts brain cells that have become inactive. This regeneration is fueled by VEGF. In the brain, VEGF stimulates the growth of blood vessels and works in other ways to keep brain cells healthy and active.

It appears that in patients with higher levels of VEGF, there was more regeneration, helping to reduce depression. Conversely, in patients with lower VEGF levels, there was less regeneration of and less relief from depression.

If the finding is confirmed by further studies, it could lead to a blood test that would help physicians tailor treatment. If, for example, a patient had low levels of VEGF, the physician might skip SSRIs and try alternative classes of antidepressants, such as bupropion, or alternative therapies, such as psychotherapy or Transcranial Magnetic Stimulation (TMG). These treatments are all available at Loyola University Medical Center.

Currently, a VEGF would be quite expensive if it were performed for a patient. But the cost likely would come down significantly if a VEGF test were to become widely used, Halaris said.

add to favorites email to friend print save as pdf

Related Stories

Anti-cancer drug damages brain vessels

Feb 11, 2008

New research may help explain why an anti-cancer drug causes potentially fatal brain inflammation in certain patients. Scientists at Harvard Medical School mimicked the drug's activity in mice and found that it damaged the ...

Recommended for you

Giving emotions to virtual characters

12 hours ago

Researchers at the Autonomous University of the State of Mexico (UAEM) were able to simulate human facial expressions in virtual characters and use them in order to create better environments within a virtual ...

Emotion-tracking software aims for "mood-aware" internet

12 hours ago

Emotions can be powerful for individuals. But they're also powerful tools for content creators, such as advertisers, marketers, and filmmakers. By tracking people's negative or positive feelings toward ads—via ...

The emotional appeal of stand-up comedy

13 hours ago

Comics taking to the stage at the Edinburgh Fringe this week should take note: how much of a hit they are with their audiences won't be down to just their jokes. As Dr Tim Miles from the University of Surrey has discovered, ...

User comments